HomeNDC LookupRxCUI directory › RxCUI 749155

Ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet — RxCUI 749155

RxNorm drug concept · Semantic clinical drug
RxCUI 749155 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 17 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI749155
Official nameEthinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asethinyl estradiol 25 MCG / norgestimate 215 MCG Oral Tablet
FDA products mapped12
Package NDCs mapped17
Reported Medicaid activity (SDUD)199,462 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Ethinyl estradiol 0.025 MG / norgestimate 0.215... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet RxCUI 749155

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Norgestimate 31994
    • Ethinyl estradiol / norgestimate 214559
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / norgestimate Oral Tablet 373121
    • Ethinyl estradiol / norgestimate Oral Product 1157363
    • Ethinyl estradiol / norgestimate Pill 1157364
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ethinyl estradiol 0.025 MG 439439
    • Norgestimate 0.215 MG 687423
  4. Packs 7

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 18 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

12 products · 17 package NDCs
17 package NDCs map to RxCUI 749155 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-2140-62 3 POUCH in 1 CARTON (0093-2140-62) / 1 BLISTER PACK in 1 PO... Tri-Lo-Sprintec Teva Pharmaceuticals USA, Inc. 2015-12-30
42291-0565-84 1 CARTON in 1 CARTON (42291-565-84) / 3 BLISTER PACK in 1 C... Norgestimate and Ethinyl Estradiol AvKARE 2020-04-20
50090-2429-00 1 KIT in 1 KIT (50090-2429-0) TRI-LO-MARZIA A-S Medication Solutions 2020-01-08
50102-0231-13 3 PACKAGE in 1 CARTON (50102-231-13) / 1 BLISTER PACK in 1... Tri-VyLibra Lo Afaxys Pharma, LLC 2016-11-04
63187-0754-28 1 BLISTER PACK in 1 POUCH (63187-754-28) / 1 KIT in 1 BLIST... TRI-LO-MARZIA Proficient Rx LP 2016-10-03
63629-2351-01 3 BLISTER PACK in 1 CARTON (63629-2351-1) / 1 KIT in 1 BLIS... Tri-Lo- Estarylla Bryant Ranch Prepack 2023-02-10
65862-0778-28 1 BLISTER PACK in 1 CARTON (65862-778-28) / 1 KIT in 1 BLIS... Tri-Lo-Mili Aurobindo Pharma Limited 2016-11-04
65862-0778-85 3 BLISTER PACK in 1 CARTON (65862-778-85) / 1 KIT in 1 BLIS... Tri-Lo-Mili Aurobindo Pharma Limited 2016-11-04
65862-0778-86 6 BLISTER PACK in 1 CARTON (65862-778-86) / 1 KIT in 1 BLIS... Tri-Lo-Mili Aurobindo Pharma Limited 2016-11-04
65862-0778-87 1 POUCH in 1 CARTON (65862-778-87) / 1 KIT in 1 POUCH Tri-Lo-Mili Aurobindo Pharma Limited 2016-11-04
65862-0778-88 3 POUCH in 1 CARTON (65862-778-88) / 1 KIT in 1 POUCH Tri-Lo-Mili Aurobindo Pharma Limited 2016-11-04
65862-0778-92 6 POUCH in 1 CARTON (65862-778-92) / 1 KIT in 1 POUCH Tri-Lo-Mili Aurobindo Pharma Limited 2016-11-04
68180-0837-73 3 POUCH in 1 CARTON (68180-837-73) / 1 BLISTER PACK in 1 PO... TRI-LO-MARZIA Lupin Pharmaceuticals, Inc. 2020-01-08
70700-0120-85 3 BLISTER PACK in 1 CARTON (70700-120-85) / 1 KIT in 1 BLIS... Tri-Lo- Estarylla Xiromed, LLC. 2023-02-10
71205-0287-28 1 BLISTER PACK in 1 POUCH (71205-287-28) / 1 KIT in 1 BLIST... Tri-Lo-Sprintec Proficient Rx LP 2019-07-01
71205-0746-28 1 BLISTER PACK in 1 BAG (71205-746-28) / 1 KIT in 1 BLISTER... Tri-Lo-Mili Proficient Rx LP 2023-01-18
72789-0435-79 1 BLISTER PACK in 1 POUCH (72789-435-79) / 1 KIT in 1 BLIST... norgestimate and ethinyl estradiol PD-Rx Pharmaceuticals, Inc. 2024-10-03
Observed labelers: Aurobindo Pharma Limited (6) · Proficient Rx LP (3) · A-S Medication Solutions (1) · Afaxys Pharma, LLC (1) · AvKARE (1) · Bryant Ranch Prepack (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.